Guidance

National Homecare Medicines Committee (NHMC) Proposal for the funding of Pharmacy Homecare Teams

4 May 2018NHMC submitted a proposal for the funding of Trust Pharmacy Homecare Teams to NHS England and NHS Clinical Commissioning for consideration. The NHMC hopes that…

National Homecare Medicines Committee (NHMC) Managing Complaints and Incidents within Homecare Services - Appendix 19 training

2 July 2018In November 2016, the Royal Pharmaceutical Society (RPS) published Appendix 19 of the Royal Pharmaceutical Society (RPS) Handbook for Homecare Services in England i.e. ‘Further…

Medicines Shortages and Patient Group Directions

16 December 2019This article outlines how PGDs can be managed to allow for their continued use in cases of medicines shortages.

National Homecare Medicines Committee (NHMC) Homecare Risk Assessment

10 December 2019To support organisations in establishing a robust risk assessment process for new homecare medicines services the NHMC has developed a tool for local use. …

Requirements for Governance and Preparation of Gene Therapy

6 February 2024Practical advice for centres implementing Gene Therapies detailing GMSC and Governance requirements and optimal preparation location.

Supply of aseptically Prepared Doses of IMPs Across Legal Boundaries Version 2 October 2019

11 November 2019This document has been developed by the NHS Quality Assurance Committee and National Pharmacy Clinical Trials Advisory Group with input provided by the MHRA Clinical…

When and how can dentists supply medicines?

28 November 2019This updated Medicines Q&A aims to explain the legal status of medicines in the UK and when and how they may be supplied by dentists…

Auditing Patient Group Directions

14 September 2020SPS have developed a template audit tool to support organisations in auditing aspects of PGD development and use.

Inclusion of dose ranges in a single Patient Group Direction

9 September 2020The below summarises the considerations required if a single PGD is to include a range of doses.

Off-label or unlicensed product use under HMR 2012 exemptions

8 January 2020The below summary details the legal position regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the HMR 2012

SPS - Specialist Pharmacy Service

NHS